title: Complement activation in factor D-deficient mice.
abstract: To assess the contribution of the alternative pathway in complement activation and host defense and its possible role in the regulation of systemic energy balance in vivo, factor D-deficient mice were generated by gene targeting. The mutant mice have no apparent abnormality in development and their body weights are similar to those of factor D-sufficient littermates. Complement activation could not be initiated in the serum of deficient mice by the alternative pathway activators rabbit erythrocytes and zymosan. Surprisingly, injection of cobra venom factor (CVF) caused a profound and reproducible reduction in serum C3 levels, whereas, as expected, there was no C3 reduction in factor B-deficient mice treated similarly. Studies of C3 and factor B activation in vitro by CVF demonstrated that in factor D-deficient serum the alpha chain of C3 was cleaved gradually over a period of 60 min without detectable cleavage of factor B. CVF-dependent C3 cleavage in the deficient serum required the presence of Mg(2+), whereas in normal mouse serum the presence of divalent cations was not required. These results suggest that in mouse proteolytic cleavage of factor B by factor D is not an absolute requirement for the zymogen to active enzyme conformational transition of CVF-bound factor B. Kinetics of opsonization of Streptococcus pneumoniae by C3 fragments was much slower in factor D-deficient serum, suggesting a significant contribution of the alternative pathway to antibacterial host defense early after infection.
authors.affiliation: Department of Medicine, University of Alabama, Birmingham, AL 35294, USA. rheu019@uabdpo.dpo.uab.edu
authors.forename: Y
authors.initials: Y
authors.lastname: Xu
authors.forename: M
authors.initials: M
authors.lastname: Ma
authors.forename: G C
authors.initials: GC
authors.lastname: Ippolito
authors.forename: H W
authors.initials: HW
authors.lastname: Schroeder
authors.forename: M C
authors.initials: MC
authors.lastname: Carroll
authors.forename: J E
authors.initials: JE
authors.lastname: Volanakis
mesh_terms: D000818:Animals; D003176:Complement C3 / Q000378:metabolism; D011415:Complement Factor B / Q000378:metabolism; D011416:Complement Factor D / Q000172:deficiency* / Q000235:genetics; D003170:Complement Pathway, Alternative; D004546:Elapid Venoms / Q000494:pharmacology; D004912:Erythrocytes / Q000276:immunology; D005260:Female; D007700:Kinetics; D008274:Magnesium / Q000494:pharmacology; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D009895:Opsonin Proteins / Q000378:metabolism; D011817:Rabbits; D013296:Streptococcus pneumoniae / Q000276:immunology; D015054:Zymosan / Q000494:pharmacology
chemical_list: D003176:Complement C3; D004546:Elapid Venoms; D009895:Opsonin Proteins; C016310:cobra venom factor; D015054:Zymosan; D011416:Complement Factor D; C493491:complement factor D, mouse; D011415:Complement Factor B; D008274:Magnesium